The predictive value of treatment response after neoadjuvant therapy

The predictive value of treatment response after neoadjuvant therapy

Triple Negative Breast Cancer: Predictive and Prognostic Biomarkers for Neo/Adjuvant TherapyПодробнее

Triple Negative Breast Cancer: Predictive and Prognostic Biomarkers for Neo/Adjuvant Therapy

The role of SERDs in the treatment landscape of patients with ER+/HER2- breast cancerПодробнее

The role of SERDs in the treatment landscape of patients with ER+/HER2- breast cancer

Immunotherapy for Muscle Invasive Bladder CancerПодробнее

Immunotherapy for Muscle Invasive Bladder Cancer

Radiotherapy for Rectal Cancer, Evolution and Current StatusПодробнее

Radiotherapy for Rectal Cancer, Evolution and Current Status

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of BenefitПодробнее

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit

2014 GICC Iris Nagtegaal, NetherlandsПодробнее

2014 GICC Iris Nagtegaal, Netherlands